Pathogen specific nucleic acid fragment and application thereof
US-2024352539-A1 · Oct 24, 2024 · US
US10280446B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10280446-B2 |
| Application number | US-201715651164-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 17, 2017 |
| Priority date | Feb 26, 2009 |
| Publication date | May 7, 2019 |
| Grant date | May 7, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure provides articles and methods useful for detecting a discrete source of DNase activity. DNase-producing microorganisms can be detected. The device can further include selective agents and/or indicators to differentiate groups or species microorganisms. Methods of use include detecting or enumerating DNase-producing microorganisms.
Opening claim text (preview).
What is claimed is: 1. A detection article, comprising: a body member comprising a self-supporting, waterproof substrate having upper and lower surfaces; wherein a dry coating comprising a cold water-soluble gelling agent and an indicator system is adhered uniformly onto a portion of at least one surface of the body member; wherein the indicator system comprises DNA and methyl green; and wherein, after contact with a predetermined volume of an aqueous liquid, the gelling agent forms a hydrogel and the concentration of methyl green in the hydrogel is about 5 μg/mL to about 20 μg/mL. 2. The article of claim 1 , wherein the coating further comprises a nutrient medium, an indicator, a selective agent, or any combination of two or more of the foregoing. 3. The article of claim 2 , wherein the selective agent selects for the growth of Staphylococcus aureus. 4. The article of claim 3 , wherein the selective agent is selected from the group consisting of cephalothin, cefazolin, cephradine, cephalexin, cefadroxil, cefamandole, cefoxitin, cefaclor, cefuroxime, cefuroxime axetil, loracarbef, cefonicid cefotetan, ceforanide, cefotaxime, cefpodoxime proxetil, ceftizoxime, cefixmeceftriaxone, cefoperazone, ceftazidime, moxlactam, cefepime, cefpirome, and oxacillin.
Ribonucleases (RNAses); Deoxyribonucleases (DNAses) · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
involving hydrolase · CPC title
entrapped within the carrier, e.g. gel or hollow fibres · CPC title
from Staphylococcus (G) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.